Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T13:14:21.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces that federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.4%
    Check dated 2026-10-26T14:25:04.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T14:47:52.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-12T15:47:47.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study record history gains a new Revision: v3.7.0 entry, while the older Revision: v3.6.6 entry is removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-21T22:47:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, was added to the study's record history and the previous entry for v3.6.5 was removed. This reflects an update to the version history of the study record.
    Difference
    0.1%
    Check dated 2026-08-31T17:10:39.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.